Dusa Pharmaceuticals (NASDAQ: DUSA) reported its Q4 EPS at $0.12, versus the consensus of $0.04. DUSA reported its Q4 revenue at $12 million, versus the consensus of $10.28 million.
DUSA shares gained 7.02% to close at $3.20 yesterday.
Read more <a href="http://www.benzinga.com/markets/company-news">from Benzinga's Company news.</a>
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Posted In:
